{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:04:58Z","timestamp":1794330298636,"version":"4.9.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["8561 and 8561.01"],"award-info":[{"award-number":["8561 and 8561.01"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1286-2","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T16:46:40Z","timestamp":1535647600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson\u2019s disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Gregory P.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrey M.","family":"Schonhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"Jurkuvenaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron D.","family":"Thome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Standaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7054-2812","authenticated-orcid":false,"given":"Ashley S.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,30]]},"reference":[{"key":"1286_CR1","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A. 1998;95:6469\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1286_CR2","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997;276:2045\u20137.","journal-title":"Science"},{"key":"1286_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.21022","volume":"60","author":"J Hardy","year":"2006","unstructured":"Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A. Genetics of Parkinson's disease and parkinsonism. Ann Neurol. 2006;60:389\u201398.","journal-title":"Ann Neurol"},{"key":"1286_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ana.21380","volume":"63","author":"OA Ross","year":"2008","unstructured":"Ross OA, Braithwaite AT, Skipper LM, Kachergus J, Hulihan MM, et al. Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann Neurol. 2008;63:743\u201350.","journal-title":"Ann Neurol"},{"key":"1286_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature17939","volume":"533","author":"F Soldner","year":"2016","unstructured":"Soldner F, Stelzer Y, Shivalila CS, Abraham BJ, Latourelle JC, et al. Parkinson-associated risk variant in distal enhancer of alpha-synuclein modulates target gene expression. Nature. 2016;533:95\u20139.","journal-title":"Nature"},{"key":"1286_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology. 1988;38:1285\u201391.","journal-title":"Neurology"},{"key":"1286_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, et al. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol. 2003;106:518\u201326.","journal-title":"Acta Neuropathol"},{"key":"1286_CR8","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest. 2009;119:182\u201392.","journal-title":"J Clin Invest"},{"key":"1286_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 2009;8:382\u201397.","journal-title":"Lancet Neurol"},{"key":"1286_CR10","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ng.642","volume":"42","author":"TH Hamza","year":"2010","unstructured":"Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet. 2010;42:781\u20135.","journal-title":"Nat Genet"},{"key":"1286_CR11","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/mds.25035","volume":"27","author":"I Ahmed","year":"2012","unstructured":"Ahmed I, Tamouza R, Delord M, Krishnamoorthy R, Tzourio C, et al. Association between Parkinson\u2019s disease and the HLA-DRB1 locus. Mov Disord. 2012;27:1104\u201310.","journal-title":"Mov Disord"},{"key":"1286_CR12","doi-asserted-by":"crossref","unstructured":"Kannarkat GT, Cook DA, Lee JK, Chang J, Chung J, et al. Common genetic variant association with altered HLA expression, synergy with Pyrethroid exposure, and risk for Parkinson\u2019s disease: an observational and case-control study. NPJ Parkinsons Dis. 2015;1","DOI":"10.1038\/npjparkd.2015.2"},{"key":"1286_CR13","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, et al. T cells from patients with Parkinson\u2019s disease recognize alpha-synuclein peptides. Nature. 2017;546:656\u201361.","journal-title":"Nature"},{"key":"1286_CR14","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","volume":"33","author":"AS Harms","year":"2013","unstructured":"Harms AS, Cao S, Rowse AL, Thome AD, Li X, et al. MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci. 2013;33:9592\u2013600.","journal-title":"J Neurosci"},{"key":"1286_CR15","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","volume":"67","author":"S Theodore","year":"2008","unstructured":"Theodore S, Cao S, McLean PJ, Standaert DG. Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol. 2008;67:1149\u201358.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1286_CR16","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","volume":"36","author":"AD Thome","year":"2016","unstructured":"Thome AD, Harms AS, Volpicelli-Daley LA, Standaert DG. microRNA-155 regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease. J Neurosci. 2016;36:2383\u201390.","journal-title":"J Neurosci"},{"key":"1286_CR17","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1073\/pnas.96.18.10338","volume":"96","author":"L Madsen","year":"1999","unstructured":"Madsen L, Labrecque N, Engberg J, Dierich A, Svejgaard A, et al. Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci U S A. 1999;96:10338\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1286_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1074-7613(00)80681-0","volume":"4","author":"CH Chang","year":"1996","unstructured":"Chang CH, Guerder S, Hong SC, van Ewijk W, Flavell RA. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 1996;4:167\u201378.","journal-title":"Immunity"},{"key":"1286_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00251-007-0262-2","volume":"60","author":"R Horton","year":"2008","unstructured":"Horton R, Gibson R, Coggill P, Miretti M, Allcock RJ, et al. Variation analysis and gene annotation of eight MHC haplotypes: the MHC haplotype project. Immunogenetics. 2008;60:1\u201318.","journal-title":"Immunogenetics"},{"key":"1286_CR20","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1101\/gr.2188104","volume":"14","author":"CA Stewart","year":"2004","unstructured":"Stewart CA, Horton R, Allcock RJ, Ashurst JL, Atrazhev AM, et al. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res. 2004;14:1176\u201387.","journal-title":"Genome Res"},{"key":"1286_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0092-8674(05)80090-X","volume":"75","author":"V Steimle","year":"1993","unstructured":"Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 1993;75:135\u201346.","journal-title":"Cell"},{"key":"1286_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1074-7613(00)80468-9","volume":"8","author":"A Muhlethaler-Mottet","year":"1998","unstructured":"Muhlethaler-Mottet A, Di Berardino W, Otten LA, Mach B. Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity. 1998;8:157\u201366.","journal-title":"Immunity"},{"key":"1286_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40478-017-0494-9","volume":"5","author":"AS Harms","year":"2017","unstructured":"Harms AS, Delic V, Thome AD, Bryant N, Liu Z, et al. alpha-synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration. Acta Neuropathol Commun. 2017;5:85.","journal-title":"Acta Neuropathol Commun"},{"key":"1286_CR24","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.2006.04310.x","volume":"100","author":"JL St Martin","year":"2007","unstructured":"St Martin JL, Klucken J, Outeiro TF, Nguyen P, Keller-McGandy C, et al. Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra. J Neurochem. 2007;100:1449\u201357.","journal-title":"J Neurochem"},{"key":"1286_CR25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.1067081","volume":"295","author":"C Lois","year":"2002","unstructured":"Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science. 2002;295:868\u201372.","journal-title":"Science"},{"key":"1286_CR26","first-page":"17","volume":"3","author":"RL Tomlinson","year":"2008","unstructured":"Tomlinson RL. Optimized production of lentivirus using FuGENE HD transfection reagent. Biochemica. 2008;3:17\u20139.","journal-title":"Biochemica"},{"key":"1286_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.expneurol.2017.11.010","volume":"300","author":"AS Harms","year":"2018","unstructured":"Harms AS, Thome AD, Yan Z, Schonhoff AM, Williams GP, et al. Peripheral monocyte entry is required for alpha-synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Exp Neurol. 2018;300:179\u201387.","journal-title":"Exp Neurol"},{"key":"1286_CR28","doi-asserted-by":"publisher","first-page":"e0140566","DOI":"10.1371\/journal.pone.0140566","volume":"10","author":"AD Thome","year":"2015","unstructured":"Thome AD, Standaert DG, Harms AS. Fractalkine signaling regulates the inflammatory response in an alpha-synuclein model of Parkinson disease. PLoS One. 2015;10:e0140566.","journal-title":"PLoS One"},{"key":"1286_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-5-42","volume":"5","author":"S Cao","year":"2010","unstructured":"Cao S, Theodore S, Standaert DG. Fcgamma receptors are required for NF-kappaB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson\u2019s disease. Mol Neurodegener. 2010;5:42.","journal-title":"Mol Neurodegener"},{"key":"1286_CR30","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1523\/JNEUROSCI.4658-15.2016","volume":"36","author":"H Qin","year":"2016","unstructured":"Qin H, Buckley JA, Li X, Liu Y, Fox TH 3rd, et al. Inhibition of the JAK\/STAT pathway protects against alpha-synuclein-induced neuroinflammation and dopaminergic neurodegeneration. J Neurosci. 2016;36:5144\u201359.","journal-title":"J Neurosci"},{"key":"1286_CR31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nri1708","volume":"5","author":"W Reith","year":"2005","unstructured":"Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol. 2005;5:793\u2013806.","journal-title":"Nat Rev Immunol"},{"key":"1286_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnmol.2018.00036","volume":"11","author":"MJ Benskey","year":"2018","unstructured":"Benskey MJ, Sellnow RC, Sandoval IM, Sortwell CE, Lipton JW, et al. Silencing alpha synuclein in mature Nigral neurons results in rapid neuroinflammation and subsequent toxicity. Front Mol Neurosci. 2018;11:36.","journal-title":"Front Mol Neurosci"},{"key":"1286_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/jnc.13627","volume":"139","author":"LA Volpicelli-Daley","year":"2016","unstructured":"Volpicelli-Daley LA, Kirik D, Stoyka LE, Standaert DG, Harms AS. How can rAAV-alpha-synuclein and the fibril alpha-synuclein models advance our understanding of Parkinson disease? J Neurochem. 2016;139:131.","journal-title":"J Neurochem"},{"key":"1286_CR34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrn.2017.75","volume":"18","author":"JB Koprich","year":"2017","unstructured":"Koprich JB, Kalia LV, Brotchie JM. Animal models of alpha-synucleinopathy for Parkinson disease drug development. Nat Rev Neurosci. 2017;18:515\u201329.","journal-title":"Nat Rev Neurosci"},{"key":"1286_CR35","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","volume":"128","author":"V Grozdanov","year":"2014","unstructured":"Grozdanov V, Bliederhaeuser C, Ruf WP, Roth V, Fundel-Clemens K, et al. Inflammatory dysregulation of blood monocytes in Parkinson\u2019s disease patients. Acta Neuropathol. 2014;128:651\u201363.","journal-title":"Acta Neuropathol"},{"key":"1286_CR36","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1182\/blood-2004-09-3445","volume":"107","author":"T Buch","year":"2006","unstructured":"Buch T, Polic B, Clausen BE, Weiss S, Akilli-Ozturk O, et al. MHC class II expression through a hitherto unknown pathway supports T helper cell-dependent immune responses: implications for MHC class II deficiency. Blood. 2006;107:1434\u201344.","journal-title":"Blood"},{"key":"1286_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17:131\u201343.","journal-title":"Nat Neurosci"},{"key":"1286_CR38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/glia.22771","volume":"63","author":"K Immig","year":"2015","unstructured":"Immig K, Gericke M, Menzel F, Merz F, Krueger M, et al. CD11c-positive cells from brain, spleen, lung, and liver exhibit site-specific immune phenotypes and plastically adapt to new environments. Glia. 2015;63:611\u201325.","journal-title":"Glia"},{"key":"1286_CR39","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","volume":"48","author":"D Mrdjen","year":"2018","unstructured":"Mrdjen D, Pavlovic A, Hartmann FJ, Schreiner B, Utz SG, et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity. 2018;48:380\u201395. e386","journal-title":"Immunity"},{"key":"1286_CR40","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1016\/j.molimm.2007.01.009","volume":"44","author":"M Zhao","year":"2007","unstructured":"Zhao M, Flynt FL, Hong M, Chen H, Gilbert CA, et al. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma. Mol Immunol. 2007;44:2923\u201332.","journal-title":"Mol Immunol"},{"key":"1286_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnmol.2015.00014","volume":"8","author":"LC Parr-Brownlie","year":"2015","unstructured":"Parr-Brownlie LC, Bosch-Bouju C, Schoderboeck L, Sizemore RJ, Abraham WC, et al. Lentiviral vectors as tools to understand central nervous system biology in mammalian model organisms. Front Mol Neurosci. 2015;8:14.","journal-title":"Front Mol Neurosci"},{"key":"1286_CR42","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","volume":"32","author":"MS Moehle","year":"2012","unstructured":"Moehle MS, Webber PJ, Tse T, Sukar N, Standaert DG, et al. LRRK2 inhibition attenuates microglial inflammatory responses. J Neurosci. 2012;32:1602\u201311.","journal-title":"J Neurosci"},{"key":"1286_CR43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2017.07.016","volume":"106","author":"I Jimenez-Ferrer","year":"2017","unstructured":"Jimenez-Ferrer I, Jewett M, Tontanahal A, Romero-Ramos M, Swanberg M. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to alpha-synuclein-induced dopaminergic neurodegeneration. Neurobiol Dis. 2017;106:279\u201390.","journal-title":"Neurobiol Dis"},{"key":"1286_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1471-4159.2005.03368.x","volume":"95","author":"CS Constantinescu","year":"2005","unstructured":"Constantinescu CS, Tani M, Ransohoff RM, Wysocka M, Hilliard B, et al. Astrocytes as antigen-presenting cells: expression of IL-12\/IL-23. J Neurochem. 2005;95:331\u201340.","journal-title":"J Neurochem"},{"key":"1286_CR45","doi-asserted-by":"publisher","first-page":"24251","DOI":"10.1038\/srep24251","volume":"6","author":"B Vagaska","year":"2016","unstructured":"Vagaska B, New SE, Alvarez-Gonzalez C, D'Acquisto F, Gomez SG, et al. MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNgamma-independent fashion and during development. Sci Rep. 2016;6:24251.","journal-title":"Sci Rep"},{"key":"1286_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1084\/jem.194.4.393","volume":"194","author":"JM Waldburger","year":"2001","unstructured":"Waldburger JM, Suter T, Fontana A, Acha-Orbea H, Reith W. Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J Exp Med. 2001;194:393\u2013406.","journal-title":"J Exp Med"},{"key":"1286_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jneuroim.2006.11.009","volume":"183","author":"C Laurie","year":"2007","unstructured":"Laurie C, Reynolds A, Coskun O, Bowman E, Gendelman HE, et al. CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. J Neuroimmunol. 2007;183:60\u20138.","journal-title":"J Neuroimmunol"},{"key":"1286_CR48","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","volume":"184","author":"AD Reynolds","year":"2010","unstructured":"Reynolds AD, Stone DK, Hutter JA, Benner EJ, Mosley RL, et al. Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson\u2019s disease. J Immunol. 2010;184:2261\u201371.","journal-title":"J Immunol"},{"key":"1286_CR49","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1038\/ncomms4633","volume":"5","author":"C Cebrian","year":"2014","unstructured":"Cebrian C, Zucca FA, Mauri P, Steinbeck JA, Studer L, et al. MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nat Commun. 2014;5:3633.","journal-title":"Nat Commun"},{"key":"1286_CR50","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","volume":"166","author":"D Matheoud","year":"2016","unstructured":"Matheoud D, Sugiura A, Bellemare-Pelletier A, Laplante A, Rondeau C, et al. Parkinson\u2019s disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation. Cell. 2016;166:314\u201327.","journal-title":"Cell"},{"key":"1286_CR51","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/nn.2917","volume":"14","author":"RM Ransohoff","year":"2011","unstructured":"Ransohoff RM. Microglia and monocytes: 'tis plain the twain meet in the brain. Nat Neurosci. 2011;14:1098\u2013100.","journal-title":"Nat Neurosci"},{"key":"1286_CR52","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nri2550","volume":"9","author":"J Goverman","year":"2009","unstructured":"Goverman J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol. 2009;9:393\u2013407.","journal-title":"Nat Rev Immunol"},{"key":"1286_CR53","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.immuni.2017.06.007","volume":"46","author":"J Herz","year":"2017","unstructured":"Herz J, Filiano AJ, Smith A, Yogev N, Kipnis J. Myeloid cells in the central nervous system. Immunity. 2017;46:943\u201356.","journal-title":"Immunity"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1286-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1286-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1286-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T19:52:11Z","timestamp":1720554731000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1286-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,30]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1286"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1286-2","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,30]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were performed in accordance with a protocol approved by the University of Alabama at Birmingham and following the NIH Guide for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"244"}}